Profusa (PFSA) Return on Invested Capital (2022 - 2025)

Profusa's (PFSA) quarterly Return on Invested Capital came in at 0.0% in Q2 2025, up 33.75% quarter-over-quarter from 0.01% in Q1 2025.

Profusa (PFSA) Return on Invested Capital (2022 - 2025) Analysis & Trends

Profusa's Return on Invested Capital history runs 3 years deep, the most recent figure standing at 0.0% for Q2 2025.

  • On a quarterly basis, Return on Invested Capital changed N/A year-over-year to 0.0% in Q2 2025; TTM through Jun 2025 was 0.0%, a N/A change from a year earlier, with the FY2022 full-year figure at 0.9%, changed N/A from the prior year.
  • Return on Invested Capital advanced to 0.0% in Q2 2025 per PFSA's latest filing, from 0.01% in the prior quarter.
  • Across five years, Return on Invested Capital topped out at 0.0% in Q2 2025 and bottomed at 0.42% in Q4 2022.
  • The 3-year median for Return on Invested Capital is 0.31% (2023), against an average of 0.23%.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) ROIC (Qtr)
1 Abbott Laboratories 201.40 Bn 194.75 Bn 6.27 Bn 0.01%
2 Stryker 122.29 Bn 119.41 Bn 3.81 Bn 0.01%
3 Medtronic 105.01 Bn 96.40 Bn 6.41 Bn 0.01%
4 Boston Scientific 64.81 Bn 63.59 Bn 3.61 Bn 0.00%
5 Edwards Lifesciences 55.28 Bn 51.60 Bn 1.29 Bn -
6 Dexcom 29.06 Bn 27.94 Bn 750.30 Mn -
7 Koninklijke Philips 29.02 Bn 25.93 Bn 2.07 Bn 0.00%
8 GE HealthCare Technologies 28.27 Bn 26.20 Bn 1.98 Bn 0.00%
9 Smith & Nephew 25.80 Bn 25.22 Bn - -
10 Profusa 23,566.40 -351,433.60 - -

Historic Data

Download Data
DateValue
Jun 30, 2025 0.00%
Mar 31, 2025 -0.01%
Sep 30, 2023 -0.31%
Jun 30, 2023 -0.34%
Mar 31, 2023 -0.30%
Dec 31, 2022 -0.42%